2024 Annual Australian Respiratory Surveillance Report
DOI:
https://doi.org/10.33321/cdi.2026.50.013Keywords:
acute respiratory disease, influenza like illness (ILI), severe acute respiratory infection (SARI), SARS-CoV-2, COVID-19, influenza, RSV, surveillance, epidemiology, AustraliaAbstract
In 2024, coronavirus disease 2019 (COVID-19), influenza, and respiratory syncytial virus (RSV) were nationally notifiable in Australia. The states and territories reported 302,250 COVID-19, 365,589 influenza, and 175,918 RSV notifications to the National Notifiable Diseases Surveillance System. Influenza and RSV notifications increased between 2023 and 2024; however, COVID-19 notifications decreased. Trends in test positivity from sentinel laboratories were generally reflective of the trends in case notifications. The weekly proportion of new ‘fever and cough’ symptoms in the community remained stable between 2023 and 2024. In contrast, influenza-like-illness notification rates for consultations at sentinel general practice sites in 2024 were higher than in previous years, reflecting increased activity in case notifications. In 2024, there were fewer sentinel hospital admissions with COVID-19 or influenza than in 2023 or 2022, and the proportion of patients admitted directly to intensive care remained low and stable. In contrast, there were more sentinel intensive care admissions for severe acute respiratory infections overall in 2024 than in 2023; however, there were fewer intensive care admissions with COVID-19 than in previous years. In 2024, deaths involving influenza and RSV increased compared to 2023, whereas deaths involving COVID-19 decreased. However, COVID-19 remains the leading cause of acute respiratory infection mortality. All three acute respiratory infections are more likely to cause death in older age groups than in younger age groups. Overall, information from Australia’s national acute respiratory infection surveillance systems indicates there was high acute respiratory infection activity with moderate severity but a lower burden on health system utilisation in 2024.
Downloads
References
Australian Government Department of Health, Disability and Ageing, Interim Australian Centre for Disease Control (ACDC). Australian National Surveillance Plan for COVID-19, Influenza, and RSV. Canberra: Australian Government Department of Health, Disability and Ageing, ACDC; 24 April 2024. Available from: https://www.health.gov.au/resources/publications/australian-national-disease-surveillance-plan-for-covid-19-influenza-and-rsv.
Australian Government Register of Legislation. National Health Security Act 2007. [Legislation.] Canberra: Australian Government; 2007. Available from: https://www.legislation.gov.au/C2007A00174.
Australian Government Register of Legislation. National Health Security (National Notifiable Disease List) Instrument 2018. Canberra: Australian Government; 2018. Available from: https://www.legislation.gov.au/F2018L00450.
Australian Government Department of Health, Disability and Ageing. National Health Security Agreement. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; November 2011. Available from: https://www.health.gov.au/resources/publications/national-health-security-agreement.
Australian Bureau of Statistics. National, state and territory population. Reference period: June 2024. [Webpage.] Canberra: Australian Bureau of Statistics; 12 December 2024. Available from: https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/jun-2024.
Australian Institute of Health and Welfare (AIHW), Metadata Online Registry. Person—Indigenous status, code N: Identifying and definitional attributes. [Webpage.] Canberra: AIHW; 2025. Available from: https://meteor.aihw.gov.au/content/602543.
Fogarty W, Lovell M, Langenberg J, Heron MJ. Deficit discourse and strengths-based approaches: changing the narrative of Aboriginal and Torres Strait Islander health and wellbeing. Melbourne/Narrm: The Lowitja Institute; 2018. Available from: https://www.lowitja.org.au/resource/deficit-discourse-strengths-based/.
Australian Government Department of Health, Disability and Ageing. CDNA surveillance case definitions. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 29 May 2022. Available from: https://www.health.gov.au/resources/collections/cdna-surveillance-case-definitions.
Australian Bureau of Statistics. Deaths due to COVID-19, influenza and RSV in Australia – 2022 – January 2025. Acute respiratory disease mortality in Australia. [Webpage.] Canberra: Australian Bureau of Statistics; 28 February 2025. Available from: https://www.abs.gov.au/articles/deaths-due-covid-19-influenza-and-rsv-australia-2022-january-2025.
Australian Bureau of Statistics. Provisional Mortality Statistics methodology. [Webpage.] Canberra: Australian Bureau of Statistics; 2024. Available from: https://www.abs.gov.au/methodologies/provisional-mortality-statistics-methodology.
National Centre for Immunisation Research and Surveillance (NCIRS). History of immunisation in Australia. [Webpage.] Sydney: Sydney Children’s Hospital Network; 2025. Available from: https://ncirs.org.au/health-professionals/history-immunisation-australia.
Carlson SJ, Innes RJI, Howard ZL, Baldwin Z, Butler M, Dalton CB. FluTracking: weekly online community-based surveillance of influenza-like illness in Australia, 2019 Annual Report. Commun Dis Intell (2018). 2023;47. doi: https://doi.org/10.33321/cdi.2023.47.14.
FluTracking. Methods for calculating Fever and Cough Incidence. [Webpage.] Newcastle: FluTracking. Available from: https://info.flutracking.net/methods/.
World Health Organization (WHO). Global Influenza Programme: WHO surveillance case definitions for ILI and SARI. [Webpages.] Geneva: WHO; January 2014. Available from: https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/case-definitions-for-ili-and-sari.
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC). SPRINT-SARI (Australia). [Webpage.] Melbourne: Monash University, ANZIC-RC; 2025. Available from: https://www.monash.edu/medicine/sphpm/anzicrc/research/sprint-sari.
Pilcher D, Coatsworth NR, Rosenow M, McClure J. A national system for monitoring intensive care unit demand and capacity: the Critical Health Resources Information System (CHRIS). Med J Aust. 2021;214(7):297–8.e1. doi: https://doi.org/10.5694/mja2.50988.
WHO. Global Influenza Programme: National Influenza Centres. [Webpage.] Geneva: WHO; 2025. Available from: https://www.who.int/initiatives/global-influenza-surveillance-and-response-system/national-influenza-centres.
Communicable Diseases Genomics Network (CDGN). AUSTRAKKA: Real-time pathogen genomics surveillance. Overview. [Internet]. Melbourne: CDGN; 2024. Available from: https://www.cdgn.org.au/austrakka.
Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5(11):1403–7. doi: https://doi.org/10.1038/s41564-020-0770-5.
WHO. Tracking SARS-CoV-2 variants. [Webpage.] Geneva: WHO; 14 April 2025. Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variants.
WHO. Global influenza surveillance and response system (GISRS): WHO Collaborating Centres. [Webpage.] Geneva: WHO; 2025. Available from: https://www.who.int/initiatives/global-influenza-surveillance-and-response-system/who-collaboration-center-erl.
Townsend JP, Hassler HB, Lamb AD, Sah P, Alvarez Nishio A, Nguyen C et al. Seasonality of endemic COVID-19. mBio. 2023;14(6):e0142623. doi: https://doi.org/10.1128/mbio.01426-23.
Australian Government Department of Health, Disability and Ageing, National Notifiable Disease Surveillance System. National Communicable Disease Surveillance Dashboard. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 2025. Available from: https://nindss.health.gov.au/pbi-dashboard/.
Lu C, Barr IG, Lambert S, Mengersen K, Wang L, Yang W et al. Shifts in seasonal influenza patterns in Australia during and after COVID-19: a comprehensive analysis. J Infect Public Health. 2025;18(1):102620. doi: https://doi.org/10.1016/j.jiph.2024.102620.
Australian Bureau of Statistics. Deaths due to COVID-19, influenza and RSV in Australia – 2022 – November 2024. Acute respiratory disease mortality in Australia. [Webpage.] Canberra: Australian Bureau of Statistics; 18 December 2024. Available from: https://www.abs.gov.au/articles/deaths-due-covid-19-influenza-and-rsv-australia-2022-november-2024.
Kaku Y, Yo MS, Tolentino JE, Uriu K, Okumura K, Ito J et al. Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants. Lancet Infect Dis. 2024;24(8):e482–3. doi: https://doi.org/10.1016/S1473-3099(24)00415-8.
Kaku Y, Uriu K, Okumura K, Ito J Sato K. Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant. Lancet Infect Dis. 2024;24(10):e609. doi: https://doi.org/10.1016/S1473-3099(24)00505-X.
WHO Technical Advisory Group on Virus Evolution. Risk evaluation of for SARS-CoV-2 Variant Under Monitoring: XEC. Geneva: WHO; 2024. Available from: https://www.who.int/docs/default-source/coronaviruse/09122024_xec_ire.pdf.
Australian Government Department of Health, Disability and Ageing. National 2020 Influenza Season Summary. Canberra: Australian Government Department of Health; 10 October 2022. Available from: https://www.health.gov.au/resources/publications/aisr-2020-national-influenza-season-summary.
Barr IG, Subbarao K. Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses. NPJ Vaccines. 2024;9(1):219. doi: https://doi.org/10.1038/s41541-024-01010-y.
Caini S, Meijer A, Nunes MC, Henaff L, Zounon M, Boudewijns B et al. Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases. Lancet Microbe. 2024;5(8):100851. doi: https://doi.org/10.1016/S2666-5247(24)00066-1.
Australian Government Department of Health, Disability and Ageing. COVID-19 vaccines. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 28 May 2024. Available from: https://www.health.gov.au/our-work/covid-19-vaccines.
Australian Government Department of Health, Disability and Ageing. Influenza (flu) vaccine. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 29 April 2025. Available from: https://www.health.gov.au/topics/immunisation/vaccines/influenza-flu-vaccine.
Australian Government Department of Health, Disability and Ageing. Respiratory syncytial virus (RSV) vaccine. [Webpage.] Canberra: Australian Government Department of Health, Disability and Ageing; 10 April 2025. Available from: https://www.health.gov.au/topics/immunisation/vaccines/respiratory-syncytial-virus-rsv-vaccine.
Trombetta CM, Kistner O, Montomoli E, Viviani S, Marchi S. Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines. 2022;10(5):714. doi: https://doi.org/10.3390/vaccines10050714.
Australian Government Department of Health, Disability and Ageing. National 2022 Influenza Season Summary. Canberra: Australian Government Department of Health, Disability and Ageing; 20 December 2022. Available from: https://www.health.gov.au/resources/publications/aisr-2022-national-influenza-season-summary.
Australian Government Department of Health, Disability and Ageing. 2019 Influenza Season in Australia; A summary from the National Influenza Surveillance Committee. Canberra: Australian Government Department of Health, Disability and Ageing; 10 September 2021. Available from: https://www.health.gov.au/resources/publications/aisr-2019-national-influenza-season-summary.
Australian Government Department of Health, Disability and Ageing. Australian Influenza Surveillance Report – 2023 End of Season Summary. Canberra: Australian Government Department of Health, Disability and Ageing; 21 December 2023. Available from: https://www.health.gov.au/resources/publications/aisr-2023-national-influenza-season-summary.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
